Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway

Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway

(2015) Giovanni Giurdanella et al.   BIOCHEMICAL PHARMACOLOGY

Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation

(2015) Zengyang Yu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy

(2015) Tapan Behl et al.   PHARMACOLOGICAL RESEARCH

Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy

(2014) Rafael Simó et al.   DIABETES CARE

Natural product inhibitors of ocular angiogenesis

(2014) Rania S. Sulaiman et al.   EXPERIMENTAL EYE RESEARCH

Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes

(2014) Xiaofei Chen et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Scutellarin Inhibits High Glucose–induced and Hypoxia-mimetic Agent–induced Angiogenic Effects in Human Retinal Endothelial Cells Through Reactive Oxygen Species/Hypoxia-inducible Factor-1α/Vascular Endothelial Growth Factor Pathway

(2014) Difei Wang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism

(2014) Chen-Yuan Gong et al.   VASCULAR PHARMACOLOGY

The Role of Microglia in Diabetic Retinopathy

(2014) Jeffery G. Grigsby et al.   Journal of Ophthalmology

Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies

(2013) Gabriella Lupo et al.   BIOCHEMICAL PHARMACOLOGY

The Association of Serum Vascular Endothelial Growth Factor and Ferritin in Diabetic Microvascular Disease

(2013) Li Guo et al.   Diabetes Technology & Therapeutics

VEGFA and tumour angiogenesis

(2013) L. Claesson-Welsh et al.   JOURNAL OF INTERNAL MEDICINE

Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats

(2012) Claudio Bucolo et al.   BIOCHEMICAL PHARMACOLOGY

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

(2012) J. W. Y. Yau et al.   DIABETES CARE

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

(2012) M. Shibuya   JOURNAL OF BIOCHEMISTRY

Vascular Complications and Diabetes: Current Therapies and Future Challenges

(2012) Abbott L. Willard et al.   Journal of Ophthalmology

Anti-Angiogenesis Drugs in Diabetic Retinopathy

(2011) V. Swetha E. Jeganathan   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1α Expression in MCF-7 Breast Cancer Cells

(2011) Jun Du et al.   PLoS One

Inflammation in diabetic retinopathy

(2011) Johnny Tang et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Cadmium Increases HIF-1 and VEGF Expression through ROS, ERK, and AKT Signaling Pathways and Induces Malignant Transformation of Human Bronchial Epithelial Cells

(2011) Yi Jing et al.   TOXICOLOGICAL SCIENCES

A review of clinical trials of anti-VEGF agents for diabetic retinopathy

(2010) Benjamin P. Nicholson et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Diabetic retinopathy

(2010) Ning Cheung et al.   LANCET

Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species

(2010) Jiazhong Sun et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY